TRACON Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on TRACON Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date TRACON Pharmaceuticals Inc Strategy Report
- Understand TRACON Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company. It develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC102 is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with VEGF inhibitors. TRC102 is a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. It also offers products for the treatment of prostate cancer, and hematologic malignancies such as myeloma. The company works in collaboration with universities and medical institutions. TRACON is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
4350 La Jolla Village Drive, Suite 800, San Diego, California, 92122
Website
www.traconpharma.com
Telephone
1 858 5500780
No of Employees
17
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
TCON (NASD)
Revenue (2022)
$12.0M
EPS
XYZ
Net Income (2022)
XYZ
87.7%
(2022 vs 2021)
Market Cap*
$3.9M
Net Profit Margin (2022)
XYZ
0.0%
(2022 vs 2021)
* As of and is in US$
TRACON Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products |
|---|
| TRC102 (Methoxyamine) |
| TRC102 (MethoxyamineHCl) |
Competitor Comparison
| Key Parameters | TRACON Pharmaceuticals Inc | Globeimmune Inc | Janssen Research & Development LLC | Resolute Pharma Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | San Diego | Louisville | Raritan | San Diego |
| State/Province | California | Colorado | New Jersey | California |
| No. of Employees | 17 | 22 | - | - |
| Entity Type | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Charles P. Theuer | Chief Executive Officer; Director; President | Executive Board | 2006 | 59 |
| Scott B. Brown | Chief Financial Officer | Senior Management | 2019 | 42 |
| Bonne Adams | Chief Operating Officer | Senior Management | 2014 | - |
| James Freddo | Chief Medical Officer | Senior Management | - | - |
| Brenda Marczi | Senior Vice President - Regulatory Affairs | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer